Katarina Nägga

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

Sara Hall, Annika Öhrfelt, Radu Constantinescu et al. · Archives of Neurology · 2012 · 470 citations

Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values

Magnus Sjögren, Hugo Vanderstichele, Hans Ågren et al. · Clinical Chemistry · 2001 · 436 citations · Full text

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Tobias Skillbäck, Bahman Farahmand, Jonathan W. Bartlett et al. · Neurology · 2014 · 265 citations

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

Shorena Janelidze, Joakim Hertze, Katarina Nägga et al. · Neurobiology of Aging · 2016 · 220 citations · Full text

Bbb Permeability, Apoe Genotype, Blood-brain Barrier Permeability +26

Cerebrospinal fluid tau and amyloid-β_1-42in patients with dementia

Tobias Skillbäck, Bahman Farahmand, Christoffer Rosén et al. · Brain · 2015 · 215 citations